Mraz Amerine & Associates’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,393
| Closed | -$283K | – | 210 |
|
|
2026
Q1 | $283K | Buy |
+2,393
| New | +$296K | 0.04% | 142 |
|
|
2025
Q4 | – | Sell |
-1,512
| Closed | -$221K | – | 197 |
|
|
2025
Q3 | $221K | Sell |
1,512
-119
| -7% | -$18K | 0.03% | 165 |
|
|
2025
Q2 | $254K | Sell |
1,631
-34
| -2% | -$5.39K | 0.04% | 162 |
|
|
2025
Q1 | $272K | Buy |
1,665
+23
| +1% | +$3.83K | 0.05% | 138 |
|
|
2024
Q4 | $268K | Sell |
1,642
-114
| -6% | -$20.4K | 0.05% | 135 |
|
|
2024
Q3 | $343K | Sell |
1,756
-64
| -4% | -$11.8K | 0.06% | 123 |
|
|
2024
Q2 | $316K | Sell |
1,820
-97
| -5% | -$16.1K | 0.06% | 129 |
|
|
2024
Q1 | $324K | Sell |
1,917
-81
| -4% | -$15.2K | 0.06% | 132 |
|
|
2023
Q4 | $394K | Hold |
1,998
| – | – | 0.08% | 123 |
|
|
2023
Q3 | $348K | Hold |
1,998
| – | – | 0.08% | 125 |
|
|
2023
Q2 | $344K | Hold |
1,998
| – | – | 0.08% | 124 |
|
|
2023
Q1 | $333K | Hold |
1,998
| – | – | 0.08% | 124 |
|
|
2022
Q4 | $293K | Hold |
1,998
| – | – | 0.07% | 138 |
|
|
2022
Q3 | $296K | Buy |
1,998
+26
| +1% | +$4.34K | 0.08% | 125 |
|
|
2022
Q2 | $339K | Sell |
1,972
-186
| -9% | -$32.2K | 0.09% | 124 |
|
|
2022
Q1 | $407K | Hold |
2,158
| – | – | 0.1% | 117 |
|
|
2021
Q4 | $527K | Sell |
2,158
-12
| -0.6% | -$2.63K | 0.14% | 97 |
|
|
2021
Q3 | $421K | Hold |
2,170
| – | – | 0.12% | 114 |
|
|
2021
Q2 | $404K | Hold |
2,170
| – | – | 0.11% | 114 |
|
|
2021
Q1 | $342K | Hold |
2,170
| – | – | 0.1% | 115 |
|
|
2020
Q4 | $359K | Sell |
2,170
-96
| -4% | -$15.6K | 0.12% | 106 |
|
|
2020
Q3 | $375K | Hold |
2,266
| – | – | 0.14% | 84 |
|
|
2020
Q2 | $311K | Sell |
2,266
-234
| -9% | -$30.6K | 0.12% | 95 |
|
|
2020
Q1 | $294K | Hold |
2,500
| – | – | 0.12% | 94 |
|
|
2019
Q4 | $331K | Hold |
2,500
| – | – | 0.09% | 117 |
|
|
2019
Q3 | $311K | Hold |
2,500
| – | – | 0.09% | 115 |
|
|
2019
Q2 | $284K | Hold |
2,500
| – | – | 0.08% | 127 |
|
|
2019
Q1 | $252K | Sell |
2,500
-586
| -19% | -$53.2K | 0.08% | 131 |
|
|
2018
Q4 | $264K | Hold |
3,086
| – | – | 0.09% | 124 |
|
|
2018
Q3 | $283K | Hold |
3,086
| – | – | 0.08% | 130 |
|
|
2018
Q2 | $263K | Buy |
+3,086
| New | +$261K | 0.08% | 133 |
|
|
2018
Q1 | – | Sell |
-3,286
| Closed | -$237K | – | 161 |
|
|
2017
Q4 | $237K | Hold |
3,286
| – | – | 0.07% | 130 |
|
|
2017
Q3 | $210K | Hold |
3,286
| – | – | 0.07% | 133 |
|
|
2017
Q2 | $205K | Buy |
+3,286
| New | +$194K | 0.06% | 138 |
|
Other funds holding ZTS
MBI
SI
MIHAS
FFM
CIM
SIM
DLA
Mraz Amerine & Associates's ZTS Position: Q2 2026 in Review
Mraz Amerine & Associates sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 2,393 shares — an estimated $283K sold.
Mraz Amerine & Associates first reported a position in ZTS in Q2 2017 and held it in 34 quarters. The position peaked at $527K in Q4 2021. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Mraz Amerine & Associates reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
- Mraz Amerine & Associates sold 2,393 Zoetis shares in Q2 2026, an estimated $283K.
- Mraz Amerine & Associates first reported a position in Zoetis in Q2 2017 and held it in 34 quarters.
- Mraz Amerine & Associates's Zoetis position peaked at $527K in Q4 2021.
- 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.